Abstract
There are limited data on the optimal management of in-stent restenosis after percutaneous coronary intervention (PCI) with bare metal stent (BMS) or drug-eluting stent (DES) implantations. We assessed the clinical presentation, the incidence, and prognosis of definite stent thrombosis or restenosis after DES implantation for treatment of restenosis.
Original language | English |
---|---|
Journal | Catheterization and Cardiovascular Interventions |
Volume | 81 |
Issue number | 2 |
Pages (from-to) | 260-5 |
Number of pages | 6 |
ISSN | 1522-1946 |
DOIs | |
Publication status | Published - Feb 2013 |
Bibliographical note
Copyright © 2012 Wiley Periodicals, Inc.Keywords
- Aged
- Angina Pectoris
- Coronary Restenosis
- Denmark
- Drug-Eluting Stents
- Female
- Humans
- Incidence
- Kaplan-Meier Estimate
- Male
- Metals
- Middle Aged
- Myocardial Infarction
- Percutaneous Coronary Intervention
- Prosthesis Design
- Recurrence
- Registries
- Risk Factors
- Thrombosis
- Time Factors
- Treatment Outcome